Old Web
English
Sign In
Acemap
>
authorDetail
>
MaryAnn Wiskerchen
MaryAnn Wiskerchen
Eli Lilly and Company
Protease
Biochemistry
Chemistry
HIV-1 protease
Organic chemistry
4
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded d-Amino Acids as P2/P3 Ligands
1996
Journal of Medicinal Chemistry
Louis Nickolaus Jungheim
Timothy Alan Shepherd
Angela J. Baxter
Jeffrey A. Burgess
Steven D. Hatch
Penny P. Lubbehusen
MaryAnn Wiskerchen
Mark A. Muesing
Show All
Source
Cite
Save
Citations (27)
Synthesis and pharmacokinetics of potent carbamate HIV-1 protease inhibitors containing novel high affinity hydroxyethylamine isosteres
1995
Bioorganic & Medicinal Chemistry Letters
William Joseph Hornback
John E. Munroe
Timothy Alan Shepherd
Steve D. Hatch
Mark A. Muesing
MaryAnn Wiskerchen
Joseph M. Colacino
Angela J. Baxter
Kenneth S. Su
Kristina M. Campanale
Show All
Source
Cite
Save
Citations (2)
POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS CONTAINING NONCODED D-AMINO ACIDS
1995
Bioorganic & Medicinal Chemistry Letters
John E. Munroe
Timothy Alan Shepherd
Louis Nickolaus Jungheim
William Joseph Hornback
Steve D. Hatch
Mark A. Muesing
MaryAnn Wiskerchen
Kenneth S. Su
Kristina M. Campanale
Angela J. Baxter
Joseph M. Colacino
Show All
Source
Cite
Save
Citations (8)
A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease
1995
Bioorganic & Medicinal Chemistry Letters
Stephen W. Kaldor
Krzysztof Appelt
James Erwin Fritz
Marlys Hammond
Thomas Alan Crowell
Angela J. Baxter
Steven D. Hatch
MaryAnn Wiskerchen
Mark A. Muesing
Show All
Source
Cite
Save
Citations (14)
1